Proteomic analysis of formalin-fixed paraffin-embedded ' glomeruli suggests depletion of glomerular filtration barrier proteins in two-kidney, one-clip hypertensive rats

Nephrology Dialysis Transplantation

Volumn 29, Issue 12, 2014, Pages 2217-2227

  Finne, Kenneth ^a   Vethe, Heidrun ^a   Skogstrand, Trude ^a   Leh, Sabine ^a,b   Dahl, Tone D ^a   Tenstad, Olav ^a   Berven, Frode S ^a,b   Reed, Rolf K ^a   Vikse, Bjørn Egil ^a,b,c  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c HAUGESUND HOSPITAL   (Norway)

Author keywords

2K1C; FFPE; Glomerulus; Hypertension; Proteomics

Indexed keywords

ACYL COENZYME A THIOESTERASE 1; ALPHA ACTININ 4; DESMIN; FORMALDEHYDE; MEMBRANE PROTEIN; NEPH1 PROTEIN; NEPHRIN; PALMITOYL COENZYME A HYDROLASE; PARAFFIN; PODOCIN; SYNAPTOPODIN; TRANSGELIN; UNCLASSIFIED DRUG; PROTEIN; PROTEOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLOMERULAR FILTRATION BARRIER; LASER MICRODISSECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEOMICS; RAT; RENOVASCULAR HYPERTENSION; TANDEM MASS SPECTROMETRY; ANIMAL; BLOOD PRESSURE; DISEASE MODEL; GLOMERULUS; HYPERTENSION; KIDNEY DISEASE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; WISTAR RAT;

ANIMALS; BLOOD PRESSURE; CHROMATOGRAPHY, LIQUID; DISEASE MODELS, ANIMAL; FORMALDEHYDE; GLOMERULAR FILTRATION BARRIER; HYPERTENSION; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; PARAFFIN; PROTEINS; PROTEOME; PROTEOMICS; RATS; RATS, WISTAR; TANDEM MASS SPECTROMETRY;

EID: 84928706078     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu268     Document Type: Article

References (71)

1. Luke RG. Hypertensive nephrosclerosis: pathogenesis and prevalence. Essential hypertension is an important cause of end-stage renal disease. Nephrol Dial Transplant 1999;14:2271-2278
2. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998;339:1448-1456
3. Ruggenenti P, Cravedi P, Remuzzi G. Mechanisms and treatment of CKD. J Am Soc Nephrol 2012;23:1917-1928
4. Haraldsson B, Nystrom J, Deen WM. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev 2008;88:451-487
5. Patrakka J, Tryggvason K. Molecular make-up of the glomerular filtration barrier. Biochem Biophys Res Commun 2010;396:164-169
6. Tryggvason SH, Guo J, Nukui M et al. A meta-analysis of expression signatures in glomerular disease. Kidney Int 2013;84:591-599
7. Navar LG, Zou L, Von Thun A et al. Unraveling the mystery of Goldblatt hypertension. News Physiol Sci 1998;13:170-176
8. Nagase M, Shibata S, Yoshida S et al. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker. Hypertension 2006;47:1084-1093
9. Kriz W, Shirato I, Nagata M et al. The podocyte's response to stress: the enigma of foot process effacement. Am J Physiol Renal Physiol 2013;304:F333-F347
10. Wang G, Lai FM, Kwan BC et al. Podocyte loss in human hypertensive nephrosclerosis. Am J Hypertens 2009;22:300-306
11. Ikeda K, Monden T, Kanoh T et al. Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffin-embedded tissue sections. J Histochem Cytochem 1998;46:397-403
12. Crockett DK, Lin Z, Vaughn CP et al. Identification of proteins from formalin-fixed paraffin-embedded cells by LC-MS/MS. Lab Invest 2005;85:1405-1415
13. Palmer-Toy DE, Krastins B, Sarracino DA et al. Efficient method for the proteomic analysis of fixed and embedded tissues. J Proteome Res 2005;4:2404-2411
14. Craven RA, Cairns DA, Zougman A et al. Proteomic analysis of formalinfixed paraffin-embedded renal tissue samples by label-free MS: assessment of overall technical variability and the impact of block age. Proteomics Clin Appl 2013;7:273-282
15. Sedor JR. Tissue proteomics: a new investigative tool for renal biopsy analysis. Kidney Int 2009;75:876-879
16. Helle F, Vagnes OB, Iversen BM. Angiotensin II-induced calcium signaling in the afferent arteriole from rats with two-kidney, one-clip hypertension. Am J Physiol Renal Physiol 2006;291:F140-F147
17. Skogstrand T, Leh S, Paliege A et al. Arterial damage precedes the development of interstitial damage in the nonclipped kidney of two-kidney, oneclip hypertensive rats. J Hypertens 2013;31:152-159
18. Hultstrom M, Leh S, Skogstrand T et al. Upregulation of tissue inhibitor of metalloproteases-1 (TIMP-1) and procollagen-N-peptidase in hypertension-induced renal damage. Nephrol Dial Transplant 2008;23:896-903
19. Hook U, Svalander CT. Agarose method for the preparation of isolated glomeruli from human renal biopsies. APMIS 1991;99:844-848
20. Vaudel M, Barsnes H, Berven FS et al. SearchGUI: an open-source graphical user interface for simultaneous OMSSA and X!Tandem searches. Proteomics 2011;11:996-999
21. Barsnes H, Vaudel M, Colaert N et al. Compomics-utilities: an open-source Java library for computational proteomics. BMC Bioinformatics 2011;12:70
22. Nagaraj N, Mann M. Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome. J Proteome Res 2011;10:637-645
23. Metz B, Kersten GF, Hoogerhout P et al. Identification of formaldehydeinduced modifications in proteins: reactions with model peptides. J Biol Chem 2004;279:6235-6243
24. Bariety J, Bruneval P, Hill G et al. Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation. J Am Soc Nephrol 2001;12:261-274
25. Ichimura K, Kurihara H, Sakai T. Actin filament organization of foot processes in rat podocytes. J Histochem Cytochem 2003;51:1589-1600
26. Fan X, Li Q, Pisarek-Horowitz A et al. Inhibitory effects of Robo2 on nephrin: a crosstalk between positive and negative signals regulating podocyte structure. Cell Rep 2012;2:52-61
27. Miner JH. Renal basement membrane components. Kidney Int 1999;56:2016-2024
28. Farrah T, Deutsch EW, Omenn GS et al. A high-confidence human plasma proteome reference set with estimated concentrations in Peptide-Atlas. Mol Cell Proteomics 2011;10:M110.006353
29. Cui Z, Yoshida Y, Xu B et al. Profiling and annotation of human kidney glomerulus proteome. Proteome Sci 2013;11:13
30. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003;83:253-307
31. Warsow G, Endlich N, Schordan E et al. PodNet, a protein-protein interaction network of the podocyte. Kidney Int 2013;84:104-115
32. Matsusaka T, Sandgren E, Shintani A et al. Podocyte injury damages other podocytes. J Am Soc Nephrol 2011;22:1275-1285
33. Hodgin JB, Borczuk AC, Nasr SH et al. A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue. Am J Pathol 2010;177:1674-1686
34. Kim YH, Goyal M, Wharram B et al. GLEPP1 receptor tyrosine phosphatase (Ptpro) in rat PAN nephrosis. A marker of acute podocyte injury. Nephron 2002;90:471-476
35. Thomas PE, Wharram BL, Goyal M et al. GLEPP1, a renal glomerular epithelial cell (podocyte) membrane protein-tyrosine phosphatase. Identification, molecular cloning, and characterization in rabbit. J Biol Chem 1994;269:19953-19962
36. Dessapt C, Baradez MO, Hayward A et al. Mechanical forces and TGF beta 1 reduce podocyte adhesion through alpha 3 beta 1 integrin downregulation. Nephrol Dial Transplant 2009;24:2645-2655
37. Chen HC, Chen CA, Guh JY et al. Altering expression of alpha 3 beta 1 integrin on podocytes of human and rats with diabetes. Life Sci 2000;67:2345-2353
38. Hayata M, Kakizoe Y, Uchimura K et al. Effect of a serine protease inhibitor on the progression of chronic renal failure. Am J Physiol Renal Physiol 2012;303:F1126-F1135
39. Yasuno K, Araki S, Sakashita H et al. Development of podocyte injuries in Osborne-Mendel rats is accompanied by reduced expression of podocyte proteins. J Comp Pathol 2013;149:280-290
40. Kaplan JM, Kim SH, North KN et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000;24:251-256
41. Dai S, Wang Z, Pan X et al. Functional analysis of promoter mutations in the ACTN4 and SYNPO genes in focal segmental glomerulosclerosis. Nephrol Dial Transplant 2010;25:824-835
42. Kretzler M, Koeppen-Hagemann I, Kriz W. Podocyte damage is a critical step in the development of glomerulosclerosis in the uninephrectomised-desoxycorticosterone hypertensive rat. Virchows Arch 1994;425:181-193
43. Tanca A, Pagnozzi D, Burrai GP et al. Comparability of differential proteomics data generated from paired archival fresh-frozen and formalinfixed samples by GeLC-MS/MS and spectral counting. J Proteomics 2012;77:561-576
44. Addis MF, Tanca A, Pagnozzi D et al. Generation of high-quality protein extracts from formalin-fixed, paraffin-embedded tissues. Proteomics 2009;9:3815-3823
45. Zhang Y, Yoshida Y, Xu B et al. Comparison of human glomerulus proteomic profiles obtained from low quantities of samples by different mass spectrometry with the comprehensive database. Proteome Sci 2011;9:47
46. Sethi S, Gamez JD, Vrana JA et al. Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway. Kidney Int 2009;75:952-960
47. Nakatani S, Wei M, Ishimura E et al. Proteome analysis of laser microdissected glomeruli from formalin-fixed paraffin-embedded kidneys of autopsies of diabetic patients: nephronectin is associated with the development of diabetic glomerulosclerosis. Nephrol Dial Transplant 2012;27:1889-1897
48. D'Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med 2011;365:2398-2411
49. Nagata M, Kriz W. Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis. Kidney Int 1992;42:148-160
50. Eng E, Veniant M, Floege J et al. Renal proliferative and phenotypic changes in rats with two-kidney, one-clip Goldblatt hypertension. Am J Hypertens 1994;7:177-185
51. Herrmann A, Tozzo E, Funk J. Semi-automated quantitative image analysis of podocyte desmin immunoreactivity as a sensitive marker for acute glomerular damage in the rat puromycin aminonucleoside nephrosis (PAN) model. Exp Toxicol Pathol 2012;64:45-49
52. Kakimoto T, Okada K, Hirohashi Y et al. Automated image analysis of a glomerular injury marker desmin in SDT rats treated with losartan. J Endocrinol 2014;222:43-51
53. Marshall CB, Krofft RD, Blonski MJ et al. Role of smooth muscle protein SM22alpha in glomerular epithelial cell injury. Am J Physiol Renal Physiol 2011;300:F1026-F1042
54. Wang X, Sakatsume M, Sakamaki Y et al. Quantitative histological analysis of SM22alpha (transgelin) in an adriamycin-induced focal segmental glomerulosclerosis model. Nephron Exp Nephrol 2012;120:e1-e11
55. Daniel C, Ludke A, Wagner A et al. Transgelin is a marker of repopulating mesangial cells after injury and promotes their proliferation and migration. Lab Invest 2012;92:812-826
56. Hunt MC, Alexson SE. The role Acyl-CoA thioesterases play in mediating intracellular lipid metabolism. Prog Lipid Res 2002;41:99-130
57. Tsukaguchi H, Sudhakar A, Le TC et al. NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J Clin Invest 2002;110:1659-1666
58. Machuca E, Hummel A, Nevo F et al. Clinical and epidemiological assessment of steroid-resistant nephrotic syndrome associated with the NPHS2 R229Q variant. Kidney Int 2009;75:727-735
59. Santin S, Tazon-Vega B, Silva I et al. Clinical value of NPHS2 analysis in early- and adult-onset steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 2011;6:344-354
60. Li MX, Kwan JS, Bao SY et al. Predicting mendelian disease-causing nonsynonymous single nucleotide variants in exome sequencing studies. PLoS Genet 2013;9:e1003143
61. Hicks S, Wheeler DA, Plon SE et al. Prediction of missense mutation functionality depends on both the algorithm and sequence alignment employed. Hum Mutat 2011;32:661-668
62. Chan PA, Duraisamy S, Miller PJ et al. Interpreting missense variants: comparing computational methods in human disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR). Hum Mutat 2007;28:683-693
63. Kopp JB, Nelson GW, Sampath K et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 2011;22:2129-2137
64. Foster MC, Coresh J, Fornage M et al. APOL1 variants associate with increased risk of CKD among African Americans. J Am Soc Nephrol 2013;24:1484-1491
65. O'Seaghdha CM, Parekh RS, Hwang SJ et al. The MYH9/APOL1 region and chronic kidney disease in European-Americans. Hum Mol Genet 2011;20:2450-2456
66. Genovese G, Friedman DJ, Ross MD et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010;329:841-845
67. Papeta N, Kiryluk K, Patel A et al. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. J Am Soc Nephrol 2011;22:1991-1996
68. Madhavan SM, O'Toole JF, Konieczkowski M et al. APOL1 localization in normal kidney and nondiabetic kidney disease. J Am Soc Nephrol 2011;22:2119-2128
69. Larsen CP, Beggs ML, Saeed M et al. Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy. J Am Soc Nephrol 2013;24:722-725
70. McCarthy HJ, Bierzynska A, Wherlock M et al. Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 2013;8:637-648
71. Buscher AK, Kranz B, Buscher R et al. Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 2010;5:2075-2084